Related Experiment Video
Updated: Jul 19, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
Mechanisms of adenosine-induced cytotoxicity and their clinical and physiological implications
Sharmila P Seetulsingh-Goorah1
1Department of Health Sciences, Faculty of Science, University of Mauritius, Redúit, Mauritius. seetulg@uom.ac.mu
Abstract:
Extracellular ATP (ATPo) and adenosine are cytotoxic to several cancer cell lines, suggesting their potential use for anticancer therapy. Adenosine causes cytotoxicity, either when added exogenously or when generated from ATPo hydrolysis, via mechanisms which are not mutually exclusive and which involve, adenosine receptor activation, pyrimidine starvation and/or increases in intracellular S-adenosylhomocysteine: S-adenosylmethionine ratio. Given that adenosine also appears to protect against cytotoxicity via mechanisms including immunity against damage by oxygen free radicals, an understanding of the contribution of adenosine to ATPo-induced cytotoxicity is thus crucial, when considering any potential therapeutic use for these compounds. However, such an understanding has been largely hindered by the fact that many studies have not focused enough on the possibility that both ATPo and adenosine may mediate cytotoxicity in the same system. Such studies can benefit from use a range of ATPo concentrations when assessing the contribution of adenosine to ATPo-induced cytotoxicity. Whilst future molecular and pharmacological studies are needed to establish the nature of the cytotoxic adenosine receptor, it is possible that more than just one adenosine receptor type is involved and that the cytotoxic receptor(s) type is more likely to have a low affinity for adenosine. Activation of the adenosine receptor(s) would thus lead to cytotoxicity only at relatively high adenosine concentrations, while lower adenosine concentrations mediate non-cytotoxic physiological effects.
Insights
Extracellular ATP (ATPo) and adenosine show potential as anticancer therapies by inducing cancer cell death. Understanding adenosine
Area of Science:
- Biochemistry
- Pharmacology
- Cancer Biology
Background:
- Extracellular ATP (ATPo) and adenosine exhibit cytotoxic effects on various cancer cell lines, indicating therapeutic potential.
- Adenosine-induced cytotoxicity can occur through exogenous administration or ATPo hydrolysis, involving adenosine receptor activation, pyrimidine starvation, and altered S-adenosylhomocysteine/S-adenosylmethionine ratios.
- Adenosine may also confer protection against cytotoxicity via antioxidant mechanisms, complicating its role in ATPo-induced cell death.
Purpose of the Study:
- To elucidate the contribution of adenosine to ATPo-induced cytotoxicity in cancer cells.
- To address the challenge of distinguishing the independent and combined effects of ATPo and adenosine in cytotoxic mechanisms.
- To investigate the characteristics of adenosine receptors involved in cytotoxicity.
Main Methods:
- Utilized a range of ATPo concentrations to assess adenosine's contribution to cytotoxicity.
- Examined mechanisms including adenosine receptor activation, pyrimidine metabolism, and S-adenosylhomocysteine/S-adenosylmethionine ratios.
- Considered potential involvement of multiple adenosine receptor subtypes with varying affinities.
Main Results:
- Adenosine contributes to ATPo-induced cytotoxicity through multiple pathways.
- Cytotoxic adenosine receptor activation likely requires relatively high adenosine concentrations, suggesting a low-affinity receptor.
- Lower adenosine concentrations may mediate physiological effects rather than cytotoxicity.
Conclusions:
- A comprehensive understanding of adenosine's role in ATPo-induced cytotoxicity is critical for developing effective anticancer therapies.
- Future molecular and pharmacological studies are necessary to identify the specific cytotoxic adenosine receptor(s).
- The identified cytotoxic adenosine receptor(s) may exhibit low affinity, mediating cell death only at elevated adenosine levels.
Related Concept Videos
Drug Toxicity: Risk factors
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cytotoxic Edema: Pathophysiology

